Viatris wins Japan approval for Wakix to treat narcolepsy, daytime sleepiness in sleep apnea patients - VTRS News | RalliesViatris wins Japan approval for Wakix to treat narcolepsy, daytime sleepiness in sleep apnea patients
V
VTRS• Japan approval for Wakix
- Japan’s health ministry granted Viatris approval for WAKIX (pitolisant) to treat excessive daytime sleepiness tied to obstructive sleep apnea.
- The clearance also covers narcolepsy type 1 and 2, with or without cataplexy.
- WAKIX becomes Japan’s first histamine H3 receptor antagonist/inverse agonist approved for these indications.
